Sanofi is a publicly traded company trading on NASDAQ, led by CEO Olivier Charmeil.
Upcoming earnings announcement for Sanofi
Past 12 earnings reports for Sanofi
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Jan 29, 2026 | Q4 2025 | $0.89Est: $0.84 | +6.0% | $13.2BEst: $13.4B | -1.9% | — |
| Oct 24, 2025 | Q3 2025 | $1.70Est: $1.60 | +6.3% | $14.5BEst: $14.5B | +0.5% | — |
| Jul 31, 2025 | Q2 2025 | $0.90Est: $0.96 | -6.1% | $11.3BEst: $11.5B | -1.7% | — |
| Apr 24, 2025 | Q1 2025 | $0.94Est: $0.95 | -0.9% | $10.4BEst: $9.8B | +6.5% | — |
| Jan 30, 2025 | Q4 2024 | $0.70Est: $0.74 | -5.4% | $11.3BEst: $10.6B | +6.7% | — |
| Oct 25, 2024 | Q3 2024 | $1.57Est: $1.39 | +12.9% | $14.8BEst: $13.9B | +6.0% | — |
| Jul 25, 2024 | Q2 2024 | $0.93Est: $0.86 | +8.1% | $11.6BEst: $11.3B | +2.3% | — |
| Apr 25, 2024 | Q1 2024 | $0.97Est: $0.94 | +3.2% | $11.4BEst: $11.1B | +2.7% | — |
| Feb 1, 2024 | Q4 2023 | $0.89Est: $1.50 | -40.7% | $11.8BEst: $12.3B | -4.1% | — |
| Oct 27, 2023 | Q3 2023 | $1.39Est: $2.26 | -38.5% | $13.0BEst: $12.6B | +3.7% | — |
| Jul 28, 2023 | Q2 2023 | $0.95Est: $1.58 | -39.9% | $10.9BEst: $11.3B | -4.1% | — |
| Apr 27, 2023 | Q1 2023 | $1.16Est: $1.87 | -38.0% | $11.0BEst: $11.3B | -2.6% | — |
We use cookies for analytics. See our Privacy and Cookie Policy.